UnileverAB InBev

Unilever vs AB InBev

Unilever vs AB InBev sets a sprawling consumer staples giant built on hundreds of household brands against a brewing behemoth that's constructed its empire on a tighter portfolio of blockbuster labels...

Why It's Moving

Unilever

Analyst Consensus Points to Modest Upside for UL Amid Steady Consumer Staples Outlook

  • Multiple firms forecast UL reaching $65-$74 by year-end 2026, implying double-digit percentage gains tied to stable margins in personal care and food segments.
  • Recent models highlight a trading range of $56-$66 for 2026, signaling resilience in consumer spending even as economic pressures linger.
  • Upgrades from firms like BofA to Strong Buy underscore Unilever's defensive positioning, drawing investor interest in a choppy macro environment.
Sentiment:
🐃Bullish
AB InBev

Analysts Rally Behind BUD with Moderate Buy Consensus Signaling Growth Potential.

  • Brokerages lean bullish with 11 Buy ratings, 4 Holds, and 1 Strong Buy, highlighting BUD's attractive valuation at a P/E of 20.79 versus peers.
  • Goldman Sachs ramped up its position by 265,783 shares to over 1.3 million worth $81M, underscoring institutional confidence in BUD's market position.
  • Strategic acquisition of BeatBox targets Gen Z drinkers, bolstering BUD's push into innovative beverages amid shifting consumer tastes.
Sentiment:
🐃Bullish

Investment Analysis

Pros

  • Unilever maintains a resilient performance with expected underlying sales growth between 3% to 5% for 2025, supported by a strong innovation pipeline and momentum in developed markets.
  • The company is improving profitability with a projected modest operating margin improvement in 2025, balancing margins more evenly across the year compared to 2024.
  • Unilever is sharpening its portfolio focus by completing the demerger of its Ice Cream business, aiming for higher structural margins and prioritising growth segments like Beauty, Wellbeing, Personal Care, and digital commerce.

Considerations

  • Unilever faces ongoing challenges from heightened global macroeconomic uncertainty and currency volatility, which could affect consumer sentiment and sales.
  • Emerging markets performance requires interventions and remains a source of uncertainty, particularly in Indonesia and China, despite expected improvements in the latter half of 2025.
  • The direct impact of tariffs, while limited, still poses a manageable profitability risk amid an uncertain regulatory and trade environment.

Pros

  • Anheuser-Busch InBev has a diversified global portfolio with approximately 500 beer brands, including strong global brands like Budweiser, Corona, and Stella Artois, which provide broad geographical and product exposure.
  • The company benefits from significant scale and strong market presence across multiple regions including North America, Latin America, Europe, Africa, and Asia Pacific.
  • Its relatively low P/E ratio compared to sector peers may indicate potential valuation attractiveness, supported by efforts in non-beer beverages and strategic bottling partnerships with PepsiCo.

Considerations

  • Anheuser-Busch InBev's market capitalization has declined by nearly 6% over the past year, reflecting stock price pressure and possibly market concerns over growth prospects or profits.
  • The company is exposed to cyclical risks and changing consumer preferences in the alcohol beverage sector, as well as competition from local and craft brewers.
  • Despite diversification, AB InBev faces operational risks tied to macroeconomic conditions globally, including inflationary pressures and regulatory challenges in various markets.

Unilever (UL) Next Earnings Date

Unilever's (UL) next earnings date is the Q1 2026 Trading Statement on April 30, 2026. This report will cover the first quarter of 2026 results. As of April 27, 2026, it is scheduled just days ahead, aligning with the company's pattern of quarterly trading updates.

AB InBev (BUD) Next Earnings Date

Anheuser-Busch InBev (BUD) is expected to report its next earnings on May 5-7, 2026, ahead of market open, covering the first quarter of 2026. This date aligns with projections from recent analyst calendars following the prior Q4 2025 release on February 12, 2026. The company has not yet officially confirmed the exact timing, consistent with its historical quarterly pattern.

Buy UL or BUD in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

UL
UL$58.53
vs
BUD
BUD$75.76